Cite
mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia
MLA
Régio Brambilla, Cláudia, et al. “MGluR5 Receptor Availability Is Associated with Lower Levels of Negative Symptoms and Better Cognition in Male Patients with Chronic Schizophrenia.” Human Brain Mapping, vol. 41, no. 10, Oct. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fd86f9f10f90a1ebbc3fc25b1e26a27c&authtype=sso&custid=ns315887.
APA
Régio Brambilla, C., Veselinović, T., Rajkumar, R., Mauler, J., Orth, L., Ruch, A., Ramkiran, S., Heekeren, K., Kawohl, W., Wyss, C., Kops, E. R., Scheins, J., Tellmann, L., Boers, F., Neumaier, B., Ermert, J., Herzog, H., Langen, K.-J., Jon Shah, N., … Neuner, I. (2019). mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia. Human Brain Mapping, 41(10).
Chicago
Régio Brambilla, Cláudia, Tanja Veselinović, Ravichandran Rajkumar, Jörg Mauler, Linda Orth, Andrej Ruch, Shukti Ramkiran, et al. 2019. “MGluR5 Receptor Availability Is Associated with Lower Levels of Negative Symptoms and Better Cognition in Male Patients with Chronic Schizophrenia.” Human Brain Mapping 41 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fd86f9f10f90a1ebbc3fc25b1e26a27c&authtype=sso&custid=ns315887.